NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR IN ANY JURISDICTION IN WHICH.
OSLO, Norway, Nov. 3, 2022 /PRNewswire/ Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector" or the "Company") announces the progress it has made in designing and developing a portfolio
Second publication reports on CD37-targeting imaging approach to select NHL patients who might respond best to Humalutin treatment OSLO, Norway, May 3, 2022 /PRNewswire/ Nordic Nanovector